ClinicalTrials.gg
Not yet recruitingNCT07528625Updated Apr 17, 2026

Behavioral Interventions as Primary Prevention for Non-Communicable Diseases Among Young People

An interventional study of health education of preventive tools for developing chronic diseases in Non Communicable Diseases and Non Communicable Chronic Diseases, sponsored by Deraya University. Not yet recruiting at 1 site in Egypt. Open to participants aged 15 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-17.

Sponsored by Deraya University · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
2,000
Allocation
Randomized
Ages
15 Years to 25 Years
Sex
All
01

Study summary

In consistence of North Africa vision to decrease incidence of NCDs in different population type investigators decide to give more concerns to youth (young old) who are the main human power to build future. Recent data report non-communicable diseases (NCDs) are the current leading cause of mortality in Egypt, with NCDs estimated to account for 85% of all deaths. Egypt's youth population (16-25 years old) is both the country's greatest asset and one of its biggest challenges. This age group makes up a huge share of the population, and while they are more connected to technology, social media, and modern facilities than older generations, they face lifestyle barriers that affect their health and productivity. Many modifiable risk factors affect their behavior and in consequence health. These factors related strongly to their close relationship with technology, they spend more time on mobile and computer applications that affect directly on physical inactivity, sleeping time (onset and duration) and at the end cause NCDs as obesity and CVs problems. Upper Egypt as apart from North Africa region is considered as one of the low-income countries with special cultures, specifically regarding food and physical activities. Even though young people constitute a significant proportion of the population, comparatively fewer studies have examined the prevalence of health concerns and the strategies needed to promote their well-being, especially when contrasted with research focused on groups such as the elderly or pregnant and lactating women. This project aims to investigate prevalence patterns, identify contributing factors, enhance community awareness by encouraging training of healthcare providers to best act and modify youth risk factors, and implement preventive interventions that are both cost-effective and sustainable. Furthermore, it seeks to foster adherence to these measures to strengthen health literacy and reduce the burden of conditions

02

Conditions studied

  • Non Communicable Diseases
  • Non Communicable Chronic Diseases

Keywords

  • young adults
  • non communicable diseases
  • behaviour intervention
03

In context

Noncommunicable Diseases

146 studies on the registry are indexed under Noncommunicable Diseases; 57 are open to participants now.

This study's planned enrollment of 2,000 is above the median of 478 across 97 interventional studies indexed under Noncommunicable Diseases.

Browse Noncommunicable Diseases studies →

Lead sponsor

Deraya University is the lead sponsor of 50 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age Range: Typically 10-19 (adolescents) or 15-24 (young adults).
  • resident in Egypt
  • accept sharing and adhered for following
  • At-risk youth (e.g., sedentary, high-sugar diet)
  • Motivated to use digital tools
  • Diverse socio-economic backgrounds
  • Healthy enough for moderate exercise
  • Presence of at least one modifiable risk factor, such as:

Insufficient physical activity (not meeting WHO guidelines of 60 min/day). Unhealthy dietary habits (high sugar/salt intake, low fruit/vegetable consumption).

Tobacco use or exposure to second-hand smoke (including vaping). Harmful alcohol consumption patterns.

Exclusion criteria

Exclusion Criteria:

  • Individuals already diagnosed with the NCDs being targeted
  • Presence of medical conditions that cause secondary obesity or hypertension
  • Current use of medications that significantly affect metabolic or behavioral outcomes
  • Individuals with active psychosis, severe clinical depression, or eating disorders
  • Severe impairments that prevent the individual from understanding the study requirements, providing informed assent, or interacting with digital intervention tools
  • Enrollment in another clinical trial or behavioral intervention that might lead to "treatment contamination."
  • Unable to consent or use tech due to severe deficit
  • Temporary residents (will move before data collection ends)
  • Safety risk (e.g., severe heart condition)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
2,000 participants (estimated)

Study arms

  • Experimental
    behavior therapy

    Behavioral: health education of preventive tools for developing chronic diseases

  • No intervention
    Control group

    Normal life style

Interventions

  • Behavioralhealth education of preventive tools for developing chronic diseases

    User Experience (UX) / User Interface (UI) design followed by rapid prototyping. Integration of Behavioral Change Techniques (BCTs) like nudging, peer-to-peer rewards, and goal setting

06

What researchers measure

Primary outcomes

  1. BMI control

    Measurements of BMI, before weigh/length square after 6 months and 1 year from following in the program

    Time frame: 6-12 months

Secondary outcomes

  1. Blood pressure contrl

    Time frame: 6-12 months

  2. Blood glucose levels

    Time frame: 6_12 months

Other outcomes

  1. Smoking cessation

    Time frame: 6-12 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2026; primary completion for Apr 2027, 12 months later.

Of 79 non-industry interventional studies with no phase under Noncommunicable Diseases, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 12 months is below that.

Counting every sponsor, half of 79 studies reached it within 17 months; a quarter within 7 and three quarters within 30.

Noncommunicable Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 30, 2026
First posted
Apr 14, 2026
StartEst.
Apr 1, 2026
Primary completionEst.
Apr 1, 2027
CompletionEst.
Jan 1, 2028
Last update
Apr 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07528625
Lead sponsor
Deraya University
Responsible party
Sponsor
First posted
Apr 14, 2026
Start date
Apr 1, 2026 (estimated)
Primary completion
Apr 1, 2027 (estimated)
Completion
Jan 1, 2028 (estimated)
Last update
Apr 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion